Biocept Inc. | Mutual Funds
Mutual Funds that own Biocept Inc.
Vanguard Extended Market Index Fund
13,914
0.61%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
12,319
0.54%
-1
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
5,223
0.23%
0
0%
07/31/2018
Vanguard Balanced Index Fund
4,063
0.18%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
2,199
0.1%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
1,892
0.08%
0
0%
09/06/2018
596
0.03%
0
0.01%
09/05/2018
AXA/Lord Abbett Micro Cap Portfolio
423
0.02%
278
0%
03/31/2018
Vanguard Institutional Total Stock Market Index Fund
313
0.01%
1
0%
07/31/2018
| Address |
5810 Nancy Ridge Drive
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.biocept.com |
| Updated |
07/08/2019 |
| Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. |
